XML 48 R36.htm IDEA: XBRL DOCUMENT v3.24.4
Acquisition of Nora Pharma Inc. (Details Narrative)
12 Months Ended
Oct. 20, 2022
USD ($)
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Oct. 20, 2022
CAD ($)
Business Acquisition [Line Items]        
Payments to acquire shares   $ (0) $ 14,346,637  
Stock issued for acquisition, value     4,514,000  
Earnout payable   2,547,831 $ 3,632,000  
Nora Pharma [Member]        
Business Acquisition [Line Items]        
Purchase price of shares $ 18,860,637      
Payments to acquire shares $ 14,346,637      
Stock issued for acquisition | shares 1,850      
Stock issued for acquisition, value $ 4,514,000      
Nora Pharma [Member] | Malek Chamoun [Member]        
Business Acquisition [Line Items]        
Earnout payable $ 3,632,000 2,547,831   $ 5,000,000
Payment of earnout liability   $ 1,084,169